Categories: Conferences

Binaytara Foundation September Conferences

Binaytara Foundation Hosted Two Conferences in September 2022

September was a busy month for the Foundation as we hosted two conferences, the Cellular Therapy Conference in Salt Lake City, Utah and the Northwest Women’s Cancer Conference in Portland, Oregon.

Cellular Therapy Conference

The 2022 Cellular Therapy Conference was held in Salt Lake City Utah on September 9th. This conference featured presentations and discussion led by experts in the cellular therapy field. During this conference, the oncologists’ presentations focused on their clinical data, observations they have made, and recommendations they want to share. 

According to the Conference overview, “The goal of this oncology conference was to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders.” 

We had about 40 attendees, including well known medical professionals and fourteen different vendor companies. Several attendees left glowing feedback.

“Very helpful in my scope as a hematology fellow. The quick topic discussion with 15-20 minute slots kept the discussion brisk and on topic. I appreciated that speakers included a fellow and an APC, and included two infectious disease specialists and a radiation oncologists.”

Conference Attendee

Northwest Women’s Cancer Conference

The second conference we held was the Northwest Women’s Cancer Conference located in Portland, Oregon on September 17th. According to the conference overview,  the goal of this activity was “to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies.”

We heard from many different qualified healthcare providers about their studies and findings within the field. Colleagues and attendees were able to ask questions and learn more about the topic being discussed. 

About 70 people from all over the nation were able to join us in Portland. This included about 25 presentations from faculty and 15 different vendors. 


The Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

6 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

6 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago